ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Family Medicine

Top Family Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HENRY SHOENTHAL MD

Family Medicine

46,331

$2.88M

1307
949 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $57

BRETT SCHARF DO

Family Medicine

36,994

$1.92M

1276
872 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $57

JOHN HABER D.O.

Family Medicine

36,692

$1.8M

1096
833 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $57

JANUSZ WOLANIN MD

Family Medicine

36,492

$1.58M

889
687 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $57

CHARLES PAGANA MD

Family Medicine

36,268

$1.88M

891
790 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $57

BRIAN KIMMEL DO

Family Medicine

34,941

$1.61M

774
676 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $57

ROBERT HAGGARD MD

Family Medicine

34,701

$1.99M

748
640 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $57

DANIEL BUBENHEIM MD

Family Medicine

32,975

$2.11M

892
710 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $57

DAVID HOYT D.O.

Family Medicine

31,649

$1.94M

1007
856 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $57

MATTHEW HALEY DO

Family Medicine

30,690

$1.94M

960
673 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $57

LARRY PLUNDO DO

Family Medicine

30,459

$2.07M

942
861 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $57

JAMES HARBERGER M.D.

Family Medicine

28,334

$1.48M

790
652 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $57

DAVID TOOMEY D.O.

Family Medicine

27,769

$1.5M

673
562 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $57

DARRYL GUISTWITE DO

Family Medicine

27,281

$1.31M

429
386 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $57

MARK WAGNER D.O.

Family Medicine

26,975

$1.6M

713
588 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $57

RANDY KREIDER MD

Family Medicine

26,952

$1.42M

727
494 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $57

THIPPESWAMY CHANNAPATI MD

Family Medicine

26,309

$1.55M

844
650 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $57

DENNIS DAVIS M.D.

Family Medicine

25,309

$1.28M

888
768 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $57

JOEL NYSTROM M.D.

Family Medicine

24,680

$1.17M

506
419 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $57

EDWARD SMITH M.D.

Family Medicine

24,631

$1.22M

897
769 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $57

JERE ESHLEMAN D.O.

Family Medicine

24,466

$1.19M

692
500 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $57

GARY WERTMAN DO

Family Medicine

24,241

$1.05M

495
409 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $57

ASHA SWAIN MD

Family Medicine

24,175

$1.46M

393
215 are 65+

29%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $57

DAVID JONES D.O.

Family Medicine

23,824

$2.22M

438
297 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $57

MICHAEL KONDASH DO

Family Medicine

23,636

$1.31M

679
570 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank